Tests and treatments
Chorionic villus sampling
What is it?What is it?
Chorionic villus sampling involves the removal of a few cells from the placenta. Because the placenta develops from the same first fertilised egg as the embryo, the chromosomes that are found in the placenta are in principle the same as the chromosomes of the baby.
Chorionic villus sampling can be performed in week 11-12 of pregnancy and the results are known after a week.
Note regarding chorionic villus sampling
In approximately 1% of cases, mosaicism is found in the placenta. This means that both normal cells and trisomy cells (of either chromosome) are found. In that case, amniocentesis must be performed as well to be certain of the karyotype (collection of chromosomes) of the baby itself.
During chorionic villus sampling, most patients experience light menstrual pain during the collection of the cells, which takes approximately 20 seconds in total.
Purpose of the procedure
The purpose of chorionic-villus-sampling/amniocentesis is generally to determine the karyotype of the baby. Reasons for this include:
- An abnormal NIPT test In this case, only amniocentesis is useful.
- An increased risk of a chromosomal abnormality after a nuchal translucency measurement and/or blood tests of the mother (the combined test).
- An abnormality in the baby that has been identified through an ultrasound.
- The prevention of a specific hereditary disease in the family, always upon consultation with the Medical Genetics Centre. Your gynaecologist will discuss this with Dr Casteels in advance or refer you in the first trimester for further consultation.
- If the reason for amniocentesis is an infection with toxoplasmosis or CMV (cytomegalovirus), you may choose to have a chromosome test at the same time. This requires the collection of more amniotic fluid, without causing any increased risk of miscarriage. You can discuss this with your gynaecologist and/or Dr Casteels.
For a swift and accurate assessment of the results of the prenatal tests, we will also ask for blood samples from both parents. This is done at the same time as chorionic villus sampling or amniocentesis.
There are however also serious chromosomal abnormalities that are not visible on a classic karotype. As some of these smaller chromosomal abnormalities may have serious consequences too, all genetic centres have been using a new test since 1 May 2013. This test is known as a microarray or molecular karotype. The cells collected through chorionic villus sampling or amniocentesis will not be subjected to classic karotype testing but to microarray testing instead. This test allows for the detection of smaller chromosomal abnormalities too.
The consent form for the microarray test can be found in the leaflet at the bottom of this page. Please complete and sign the form and bring it with you when coming in for the procedure.
Test procedureTest procedure
You will first have an informative meeting about the details of the procedure. There will be ample opportunity to discuss any questions you may have. Using the information leaflet that you can read in advance, you will be able to ask targeted questions. Next, an ultrasound is carried out, followed by the amniocentesis. Blood samples will be collected from both parents at the Blood Testing Unit. Fasting is not necessary for this. If the mother’s blood type is rhesus negative and the father’s is rhesus positive, the mother will also be administered a RhoGAM injection. This will prevent the mother from producing antibodies to the rhesus factor as a result of the procedure.
You may go home immediately after the test. You will be given a medical certificate for two days’ sick leave. If required, your partner can ask for a written confirmation of attendance for the consultation.
Please bring the following documents with you:
- identity card
- the mother’s blood type card
- physician/gynaecologist referral letter (if applicable)
- you do not need to bring money, as you will receive an invoice in the post
Possible risksPossible risks
Both procedures, amniocentesis as well as chorionic villus sampling, have a small associated risk of miscarriage which is approximately 5%. This is related to the possibility of infection, bleeding or loss of amniotic fluid (and is not related to the baby being touched). During the procedures, an ultrasound scan is used for visualisation and you will be able to view the procedure being performed on the screen.
You may go home immediately after the procedure. You will have two days’ sick leave, that is the day of the procedure itself and the following day. We recommend to take it easy during those two days: no strenuous effort (e.g. cleaning, lifting children) or long walks. You do not need to observe bed rest: small activities such as a little cooking or desk work are permitted. After the two days, you can resume your normal activities.
Your partner can of course be given a certificate for the absence from work.
You may experience a slight tummy ache on the day after the procedure (like menstrual pain). This is completely normal. You are free to take pain relief (preferably paracetamol). If you take it easy, the pain will disappear by itself over the course of the day. You should not have any significant symptoms the following day. Contact your gynaecologist if you have any of the following symptoms (in the days following the amniocentesis procedure): loss of amniotic fluid, blood loss, persistent tummy pain or fever.
The results of the chorionic villus sampling/amniocentesis will be sent directly from the Medical Genetics Centre in Ghent to your gynaecologist.
- For each procedure performed on a Monday, Tuesday or Wednesday you may contact your gynaecologist on the Friday after 4pm. If you are unable to reach your gynaecologist you may also telephone the secretariat of Dr Casteels (09 220 30 88) or the Medical Genetics Centre directly, until 5pm (09 332 36 03)
- If the procedure is performed on a Thursday or Friday, the results will only be known on the following Friday.
Centres and specialist areasCentres and specialist areas
Latest publication date: 05/02/2021